Exercise in Hereditary ATTR (ATTRv) Amyloidosis
Sponsored by University of Maia
About this trial
Last updated 10 months ago
Study ID
212/2024
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All Sexes
Trial Timing
Started 2 years ago
What is this trial about?
This study aims to explore the effects of a 12-week exercise intervention on the physical and mental health of people living with Hereditary ATTR (ATTRv) Amyloidosis, a rare genetic disease caused by mutations in the transthyretin gene, leading to the deposition of amyloid fibrils in nerves and organs.
What are the participation requirements?
Inclusion Criteria
* ATTRv Amyloidosis patients living in Portugal;
* Disease stage 1 or 2;
* No medical contraindication for exercising;
* Ability to provide informed consent.
Exclusion Criteria
- Having undergone a liver transplant in the past 6 months.